Women@SLS, formerly Medtech Women @SLS and Medtech Women @SEMDA, is a group dedicated to enhancing opportunities for women in the medtech and life science industries.
The group’s inaugural event was held in 2016. Following the event, Founding Chair Tiffany Wilson wrote:
It takes a village to continue to begin to realize the full development capabilities of the southeast’s medtech ecosystem and you are all a part of it. I would especially like to thank Executive Director Jason Rupp, the Office of Innovation & Entrepreneurship (OIE) at the U.S. Department of Commerce and our stellar roster of panelists and speakers. The insights you delivered provided the perfect launching pad for the group’s vision of serving as a strong advisory network for mentoring and professional development for female professionals and innovators across the medical technology industry in the Southeast. We want to see more women positioned for executive leadership in the industry and involved in the entrepreneurial process. Diversity and inclusion matters.”
Since its inception, Women@SLS / Medtech Women@SLS has evolved to include an advisory board of medtech and life science executives, physicians and entrepreneurs. The group conducts regularly scheduled educational programs, webinars and has expanded its capabilities and reach in large part thanks to the merging of the Southeastern Medical Device Association (SEMDA) with SE BIO into Southeast Life Sciences.
In July 2020, Allyson Bower-Willner, Marketing Director for Strategic Accounts with Molynlycke Health Care, assumed the duties of chairperson. She has served on the Women@SLS / Medtech Women @SLS board since its inception in 2016.
“Our goal is to continue our work making the southeast a world-class region for the medical device and [life science] industries,” Willner said. “Women@SLS can play an integral role in that mission by enhancing the opportunities for female inventors, entrepreneurs, and other industry professionals in the southeast.”
We founded Medtech Women @SLS, now Women@SLS, to serve as a strong advisory network for mentoring and professional development for female professionals and innovators across the medical technology industry in the Southeast. There is a meaningful gender gap in the C Suite. We know this. At the same time we are seeing more female technologists — doctors and engineers — with their names on patents, but we are not seeing a corresponding jump in the number of women involved in medtech startups.”
Alexandria Henry-Smith, Morehouse School of Medicine researcher and PhD candidate on the southeast life sciences and Women@SLS community means to her, and can mean to others. Alexandria Henry-Smith’s mother made a highly intentional effort to expose her daughter to science, including in her homeschooling through the third grade. Her
The 2021 AdvanSE Conference by Southeast Life Sciences brought together key players in the Southeast entrepreneurial ecosystem and beyond to help further our mission of fostering life science innovation and investment across the region for the greater good. The closing keynote for this year’s conference was presented by Dr. Vivian S.
Southeast Life Sciences was thrilled to return to an in-person hybrid event for the 2021 edition of our AdvanSE Conference, once again bringing together innovators, investors, corporate partners, and companies advancing our mission of cultivating, convening, and connecting the Southeast entrepreneurial ecosystem to foster life science innovation & investment across
A Southeast Life Sciences Q&A with Mammoth Scientific COO Kimberly Mackrill. Mammoth Scientific occupies a unique position in the world of life science investing. Its founding team, which includes experts in medical, spinal, financial advisory and fintech all found venture investing cumbersome for most investors. Mammoth is built to
No matter the brilliance of the research, or researcher, life science innovation relies on a rigorous regulatory and commercialization pathway before its potential to improve lives can enter patient care, at almost any scale. Universities rely on their technology transfer offices and commercial entities like Bayer to pull high
A Southeast Life Sciences Q&A with AskBio Co-Founder and CEO Sheila Mikhail “The field of gene therapy was in a nuclear winter in 2001,” said AskBio Co-Founder and CEO Sheila Mikhail. Motivated by belief in the science of gene therapy in order to give the blind a chance
On Thursday, June 24, Southeast Life Sciences hosted the virtual SE Color Pitches and Women@SLS Conference that featured a dynamic group of presenters and speakers discussing some of the biggest challenges that women and minorities continue to face in the industry today. Here are some of the key insights and
We are very excited to announce that our Keynote Speaker this year will be Dr. Michelle McMurry-Heath, President & CEO of the Biotechnology Innovation Organization, who took over the CEO position at BIO in June, replacing Jim Greenwood. I’ve spoken to many of my former colleauges at BIO, who say
During the 2020 Medtech Women AdvanSE of Southeast Life Sciences (formerly Medtech Women@SEMDA) virtual event on September 8, 2020, Founder, Chair and GCMI CEO Tiffany Wilson will pass the gavel to Allyson Bower-Willner. Willner, Marketing Director for Strategic Accounts with Molynlycke Health Care, has served on the MW@S board since
As we recently recognized in a conversation with Florence Hudson, there is a LOT to unpack when it comes to blockchain in health care. But the industry has definitely taken notice of Patientory, whose team and distributed ledger technology is starting to revolutionize EHRs and the way doctors and patients interact with each
Three years, two rounds and one ‘market reprioritization later,’ SweetBio is poised to enter the $10 billion wound care market this year. While FDA work continues on a first in kind pre-implant dental application of its Manuka honey and collagen derivative membrane product Apis, the company has pivoted to a planned, but
Three weeks before SEMDA 2015, SweetBio wasn’t even incorporated. Six months later, Innova and MB Venture Partners co-led a $900,000 seed round to support FDA 510(k) clearance and commercialization of the company’s Guided Tissue Regeneration Membrane (GTR). A graduate of ZeroTo510, listed among TechCrunch’s Top 20 U.S. Accelerators, SweetBio has created a patent-pending
We encourage all members of the southeast life science ecosystem to engage with Women@SLS. We hope you will stay connected with us via LinkedIn and Twitter so that we might continue to build our community to the advantage of all concerned.